S457-0913 Screening compound: 1-(2H-1,3-benzodioxole-5-carbonyl)-3-[4-(3-cyclopropyl-1,2,4-oxadiazol-5-yl)-1H-1,2,3-triazol-1-yl]piperidine

S457-0913 Screening compound: 1-(2H-1,3-benzodioxole-5-carbonyl)-3-[4-(3-cyclopropyl-1,2,4-oxadiazol-5-yl)-1H-1,2,3-triazol-1-yl]piperidine
S457-0913 Screening compound: 1-(2H-1,3-benzodioxole-5-carbonyl)-3-[4-(3-cyclopropyl-1,2,4-oxadiazol-5-yl)-1H-1,2,3-triazol-1-yl]piperidine alternative view

Chemical Structure Depiction of ChemDiv screening compound S457-0913
1-(2H-1,3-benzodioxole-5-carbonyl)-3-[4-(3-cyclopropyl-1,2,4-oxadiazol-5-yl)-1H-1,2,3-triazol-1-yl]piperidine

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

S457-0913

Molecular Formula

C20H20N6O4 (C20 H20 N6 O4)

Compound Name

1-(2H-1,3-benzodioxole-5-carbonyl)-3-[4-(3-cyclopropyl-1,2,4-oxadiazol-5-yl)-1H-1,2,3-triazol-1-yl]piperidine

IUPAC name

1-(2H-13-benzodioxole-5-carbonyl)-3-[4-(3-cyclopropyl-124-oxadiazol-5-yl)-1H-123-triazol-1-yl]piperidine

SMILES

O=C(c(cc1)cc2c1OCO2)N(CCC1)CC1n1nnc(-c2nc(C3CC3)no2)c1

InChI

InChI=1S/C20H20N6O4/c27-20(13-5-6-16-17(8-13)29-11-28-16)25-7-1-2-14(9-25)26-10-15(22-24-26)19-21-18(23-30-19)12-3-4-12/h5-6,8,10,12,14H,1-4,7,9,11H2/t14-/m0/s1

InChI Key

QJDGKWCDTCLHDR-AWEZNQCLSA-N

MDL Number (MFCD)

MFCD28994389

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

408.42

Hydrogen Bond Acceptors Count

9.00

Hydrogen Bond Donors Count

0.00

Rotatable Bond Count

5.00

Number of Nitrogen and Oxygen Atoms

10

Partition Coefficient, logP

2.070

Distribution Coefficient, logD

2.070

Water Solubility, LogSw

-2.56

Polar Surface Area

91.871

Acid Dissociation Constant (pKa)

23.22

Base Dissociation Constant (pKb)

2.75

Number of Chiral Centers

1.00

Percent sp3 carbon bonding

45.00

S457-0913 in Drug Discovery

Included in Screening Libraries

PPI Helix Turn 3D-Mimetics Library (71298 compounds)

Protein-Protein Interaction Library (218420 compounds)

Alpha-Helix Mimetics Library (25899 compounds)

Anti-HIV1 Library (19540 compounds)

Beyond the Flatland Library sp3 enriched (92988 compounds)

Included in 1.7M Stock Database

Mechanism of action:
  • PPI modulators
  • PPI modulators
  • PPI modulators
Structure:
  • Mimetics
  • Mimetics
  • Cyclic compounds
Therapeutical areas:
  • Antiviral
  • Infections
  • Immune system

References: we are preparing a list of scientific research reports with S457-0913 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound S457-0913?
Check Price and Availability of S457-0913, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of S457-0913 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for S457-0913
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for S457-0913
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of S457-0913 available by request